The Possibility of an Infectious Etiology of Alzheimer Disease

Area of Science:

• Neuroscience
• Infectious Diseases
• Immunology

Background:

• Alzheimer disease (AD) is increasingly linked to infectious agents, suggesting a role in AD-associated inflammation.
• Amyloid-beta (Aβ), an antimicrobial peptide, may accumulate due to infections, contributing to AD pathology.
• Specific pathogens like spirochetes, HSV-1, and Chlamydia pneumoniae are associated with AD hallmarks.

Purpose of the Study:

• To explore the potential role of bacterial, fungal, and viral infections in the causation and progression of Alzheimer disease.
• To discuss therapeutic strategies targeting infections to manage AD.

Main Methods:

• Review of existing literature on infectious agents and their association with Alzheimer disease.
• Analysis of the role of microbial components in activating inflammatory pathways and Aβ deposition.
• Examination of antimicrobial properties of Aβ and its potential infection-induced accumulation.

Main Results:

• Infections can enhance the expression of pro-inflammatory molecules via bacterial ligands and pathogen nucleic acids.
• Neurons infected with HSV-1 show accumulation of Aβ and hyperphosphorylated Tau.
• Aβ acts as an antimicrobial peptide, potentially explaining its accumulation in response to infection.

Conclusions:

• Bacterial, fungal, and viral infections are implicated in the causation and progression of Alzheimer disease.
• Combined anti-inflammatory, anti-viral, and antibiotic therapies may offer a strategy to prevent AD progression.
• Further research into the infectious etiology of AD is warranted to develop targeted treatments.